A Post-Marketing Safety Study to Evaluate the Occurrence of Aseptic Meningitis Syndrome (AMS) in an Adult Population Treated with Intragam® 10 NF

The purpose of this study is to collect data. The sponsor will be collecting medical information from study participants (through an interview and a phone call up to 7 days …

CONDITION: Blood

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Terminated

Weekend Study

20150164: This study is investigating a drug that has been developed for the treatment of a disease called Paroxysmal nocturnal hemoglobinuria (PNH) – PNH is a disease where red blood …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 45 years

TRIAL STATUS: Completed

Probiotic Clinical Trial

Are you in Good Health? Are you aged 18 or over? Do you live in Sydney? You may qualify* to take part in a trial looking at the potential changes …

CONDITION: Oral and Gastrointestinal

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

COMPARE Aphasia Trial

What is COMPARE? COMPARE is an Australian national randomised controlled trial which aims to compare two types of intensive speech pathology treatments (Constraint Induced Aphasia Therapy; Multi-modality Aphasia Therapy) to …

CONDITION: Stroke

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

LE16072 Healthy Volunteer Trial

This is a phase I study assessing the safety and tolerability of single dose of a study drug which is being developed for the treatment of hyperuricemia and gout. Eligible …

CONDITION: Other

GENDER: Males

AGE GROUP: 18 to 50 years

TRIAL STATUS: Closed: follow-up complete

LE16053 Healthy Volunteer Trial

This is an open label, phase I study assessing the safety and tolerability of a pharmaceutical formulation comprising a protein that is being developed as a treatment for acute ischemic stroke. …

CONDITION:

GENDER: Both males and females

AGE GROUP: 18 to 50 years

TRIAL STATUS: Closed: follow-up continuing

Stage III Non-Small Cell Lung Cancer

This study for patients with Stage III non-small cell lung cancer seeks to assess whether the addition of oral veliparib versus placebo to Paclitaxel/Carboplatin-based chemoradiotherapy with Paclitaxel/Carboplatin consolidation will improve …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Terminated

A Randomised Controlled Trial of Antivenom for Red-Bellied Black Snake Envenoming (RBBS)

The purpose of this project is to investigate the effectiveness and safety of early antivenom administration for the treatment of red-bellied black snake bites/envenoming. Red-bellied black snakebites (RBBS) are the …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

Mild to Moderate Knee Pain

Do you have a painful and stiff knee? Does it affect your ability to talk long distances, to walk up flights of stairs?  Is Your knee pain affecting your sleep …

CONDITION: Musculoskeletal

GENDER: Both males and females

AGE GROUP: 21 to 75 years

TRIAL STATUS: Recruiting

Randomised Controlled Trial of Early Antivenom Administration in Australian Snakebite [ESAA]

Snake bites are not common in Australia, but cause severe effects and often occur in rural and regional parts of Australia. Antivenoms exist for the treatment of many of these …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

LE16061 Healthy Volunteer Trial

A Phase 1, Single-Center, Open-label Study to Evaluate the Safety and Pharmacokinetics of Two Tablet Formulations of PRN1008. The purpose of this study is to investigate the relative bioavailability (the …

CONDITION:

GENDER: Both males and females

AGE GROUP: 18 to 65 years

TRIAL STATUS: Closed: follow-up complete

A Phase I/IIa Study of the Efficacy and Safety of ASN-002 in Adult Patients with Low-Risk Nodular Basal Cell Carcinoma

Have you been diagnosed with or suspected to have a nodular Basal Cell Carcinoma (BCC)?   CLINICAL RESEARCH STUDY We are seeking volunteers with nodular BCC to participate in a …

CONDITION: Cancer

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting

Atopic Dermatitis

This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

Genital Psoriasis

Genital Psoriasis  If you have psoriasis with genital involvement, you’re not alone. Up to two thirds of people with psoriasis report genital involvement at some point during their lives. That’s …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

Mild To Moderate Plaque Psoriasis

AKP-11 is being developed as a treatment for psoriasis. AKP-11 has been tested on a small population of psoriasis subjects previously, which showed a reduction in psoriasis severity. By participating …

CONDITION: Skin

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

COPD – FLASH STUDY – Multi-centre

Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 40 and above

TRIAL STATUS: Completed

CHRONIC PAIN – Survey Assessment

people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, …

CONDITION: Other

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

COPD – FLASH Study

 If you answered yes to these questions, you may be able to take part in a new research study.   Our Research Centre in Drummoyne is participating in the study. …

CONDITION: Respiratory

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Closed: follow-up continuing

An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will …

CONDITION: Mental Health

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Completed

ODYSSEY – Type 2 Diabetes and High Cholesterol

We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.

CONDITION: Metabolic and Endocrine

GENDER: Both males and females

AGE GROUP: 18 and above

TRIAL STATUS: Recruiting